Trial Profile
Retrospective cohort study investigating the effect of addition of rifaximin to standard therapy on risk for first esophageal variceal bleed (EVB) in patients with esophageal varices
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary) ; Beta-adrenergic receptor antagonists
- Indications Oesophageal varices
- Focus Therapeutic Use
- 23 Dec 2015 New trial record